4//SEC Filing
Goldan Keith A. 4
Accession 0001562180-23-000953
CIK 0001395937other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:00 PM ET
Size
5.4 KB
Accession
0001562180-23-000953
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Award
Stock Options (Right to buy)
2023-02-02$28.55/sh+110,000$3,140,500→ 110,000 totalExercise: $28.55Exp: 2033-02-02→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option shall vest monthly over a four-year period.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:00 PM ET
- Size
- 5.4 KB